HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Pacific Communications President Ryan Abbate said he will retire at the end of the year.
Irvine-based biotechnology company AtheroNova Inc. priced an offering of 4 million shares of its stock and warrants to buy its stock.
Tenet Healthcare Corp. said today that Audrey Gregory is the new chief executive of Placentia-Linda Hospital.
Mission Viejo-based CareTrust REIT Inc. said today that it will spend $12 million to buy three senior housing facilities.
Valeant Pharmaceuticals International Inc. said today it would be willing to raise its hostile takeover bid for Irvine-based Allergan Inc. to $200 a share.
FDA OK’d Their Laser for Cataract Surgery Use
Abbott Medical Optics, a Santa Ana-based business unit of Chicago-based Abbott Laboratories, is introducing a pair of products for laser cataract surgeries.
Not much math but plenty of tea leaves to read on the Pimco-Janus front.
HEALTHCARE: No word yet on successor to veteran exec
Kaiser Foundation Hospitals and Health Plan is set to get a new top official in Orange County.
REAL ESTATE: GE Capital backs firm’s first OC deal
Cypress West Realty Partners LLC, a Ladera Ranch-based investor in healthcare properties, has made a medical building in Rancho Santa Margarita its first local purchase.
HEALTHCARE: Q3 boost; Allergan gives lengthy critique
Valeant Pharmaceuticals International Inc. got some traction on its hostile takeover attempt of Allergan Inc. last week, with a third-quarter earnings report reversing a weekslong dip that had dragged its bid below the market value of the Irvine-based drugmaker.
Irvine-based Kareo Inc. said today that it received $15 million in mezzanine debt financing, bringing its total capital raised this year to $47 million.
Irvine-based Edwards Lifesciences Corp. after markets closed Thursday posted third-quarter financial results that exceeded expectations, and the stock continued to rise on Friday.
University of California-Irvine announced it will conduct clinical trials for stem cell treatment in partnership with University of California-Los Angeles under an $8 million grant.
HEALTHCARE: Ackman goes on offensive, questions continue
Irvine-based Allergan Inc.’s long-running battle to stay independent marches on as hostile pursuer rhetoric heats up and many analysts express doubt about the deal going through.
HEALTHCARE: Alphaeon closes in on nine figures
Irvine-based Alphaeon Corp.’s focus on “lifestyle healthcare” is pushing the company close to nine figures in revenue and positioning it for a potential initial public offering.